← Back to Search

Monoclonal Antibodies

AXT107 0.1 mg for Diabetic Macular Edema (CONGO Trial)

Phase 1 & 2
Waitlist Available
Research Sponsored by AsclepiX Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0 to week 48
Awards & highlights

CONGO Trial Summary

This trial is testing a new drug for treating diabetic macular edema. The safety and effectiveness of the drug will be assessed over 48 weeks in up to 18 patients.

Eligible Conditions
  • Diabetic Macular Edema

CONGO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0 to week 48
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 to week 48 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety as Assessed by Incidence of Adverse Events (AEs)
Secondary outcome measures
Efficacy as Assessed by Central Retinal Thickness (CST)
Diabetic Retinopathy

CONGO Trial Design

3Treatment groups
Experimental Treatment
Group I: Mid DoseExperimental Treatment1 Intervention
AXT107 0.25 mg/eye
Group II: Low DoseExperimental Treatment1 Intervention
AXT107 0.1 mg/eye
Group III: High DoseExperimental Treatment1 Intervention
AXT107 0.5 mg/eye

Find a Location

Who is running the clinical trial?

AsclepiX Therapeutics, Inc.Lead Sponsor
2 Previous Clinical Trials
18 Total Patients Enrolled
Amir Shojaei, PhDStudy DirectorAsclepix Therapeutics
1 Previous Clinical Trials
3 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema
2020. "Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04697758.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top